Intellia Therapeutics (NTLA) announced the appointment of Brian Goff to its board of directors. Since 2022, he has been the CEO of Agios Pharmaceuticals (AGIO) and a member of its board of directors
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NTLA:
- Cathie Wood’s ARK Investment bought 47K shares of Intellia Therapeutics today
- Cathie Wood’s ARK Investment bought 137K shares of Intellia Therapeutics today
- Biotech Alert: Searches spiking for these stocks today
- Cathie Wood’s ARK Investment bought 174K shares of Intellia Therapeutics today
- Intellia announces long-term data from ongoing Phase 1 study of NTLA-2002